DNA vaccine containing specific epitope of apolipoprotein (a)
US9913886B2 · kind B2 · utility
4Cited by
6References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2016 |
| Grant date | Mar 13, 2018 |
| Priority date | — |
| Expiry date | Jul 1, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2730/10171
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an agent for the treatment or prophylaxis of arteriosclerosis comprising an expression vector encoding a chimeric Hepatitis B virus core antigen polypeptide inserted with an amino acid sequence containing a specific epitope of apolipoprotein (a), wherein the amino acid sequence containing the specific epitope is inserted between the amino acid residues 80 and 81 of the hepatitis B virus core antigen polypeptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.